NCCLS eNews - 4 February 2004 (Plain Text Version)Return to Graphical Version | Search back issues | Print all articles In this issue: Press Releases(GP28-P) Microwave Device Use; (M33-A) Antiviral Susceptibility Testing; and (MM7-A) FISH Methods for Medical Genetics NCCLS Announces Availability of New NCCLS Document on Microwave Device Use in the Clinical Laboratory; Proposed Guideline NCCLS document GP28-P — Microwave Device Use in the Clinical Laboratory; Proposed Guideline, provides recommendations for quality assurance and safety procedures for microwave equipment use, and provides a means to understand and troubleshoot conditions that contribute to variability in microwave-accelerated procedures in human clinical, veterinary, and research histopathology laboratories. Read the complete press release. NCCLS Announces Availability of New NCCLS Document on Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard NCCLS document M33-A — Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus. Read the complete press release. NCCLS Announces Availability of New NCCLS Document on Fluorescence In Situ Hybridization (FISH) Methods for Medical Genetics; Approved Guideline NCCLS document MM7-A — Fluorescence In Situ Hybridization (FISH), Methods for Medical Genetics; Approved Guideline, may be used to detect cytogenetic aberrations that are not readily evident by standard cytogenetic banding analyses. Read the complete press release. View the complete listing of NCCLS press releases. For more information or to contact us directly, please visit www.nccls.org l ©2004 NCCLS |